Managing Patients with Hemophilia: Factor Replacement and Infectious Disease Considerations

This chapter delves into the importance of proper port placement for patients needing prophylaxis with factor concentrate, warning against the risks of hematoma formation from IM administration. It also discusses the historical risks of infectious diseases in hemophilia patients, the necessity of immediate clotting factor replacement, dosage recommendations, inhibitor development complications, and the significance of consulting hematology specialists.